Cell-Targeted Long-Acting Nanoformulated Antiretroviral Therapy

被引:0
|
作者
Puligujja, Pavan [1 ]
Veerubhotla, Ram [1 ]
McMillan, JoEllyn [1 ]
Gendelman, Howard [1 ]
Liu, Xinming [1 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE USA
关键词
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
P178
引用
收藏
页码:88 / 88
页数:1
相关论文
共 50 条
  • [1] Preclinical Pharmacokinetics and Tissue Distribution of Long-Acting Nanoformulated Antiretroviral Therapy
    Gautam, Nagsen
    Roy, Upal
    Balkundi, Shantanu
    Puligujja, Pavan
    Guo, Dongwei
    Smith, Nathan
    Liu, Xin-Ming
    Lamberty, Benjamin
    Morsey, Brenda
    Fox, Howard S.
    McMillan, JoEllyn
    Gendelman, Howard E.
    Alnouti, Yazen
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (07) : 3110 - 3120
  • [2] Long-acting antiretroviral therapy
    Soriano, Vicente
    Barreiro, Pablo
    de Mendoza, Carmen
    [J]. NATURE MATERIALS, 2020, 19 (08) : 826 - 827
  • [3] Long-acting antiretroviral therapy
    Vicente Soriano
    Pablo Barreiro
    Carmen de Mendoza
    [J]. Nature Materials, 2020, 19 : 826 - 827
  • [4] Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients
    Williams, Jennifer
    Sayles, Harlan R.
    Meza, Jane L.
    Sayre, Patrick
    Sandkovsky, Uriel
    Gendelman, Howard E.
    Flexner, Charles
    Swindells, Susan
    [J]. NANOMEDICINE, 2013, 8 (11) : 1807 - 1813
  • [5] Development of HIV Reservoir Targeted Long Acting Nanoformulated Antiretroviral Therapies
    Edagwa, Benson J.
    Zhou, Tian
    McMillan, JoEllyn M.
    Liu, Xin-Ming
    Gendelman, Howard E.
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (36) : 4186 - 4198
  • [6] Creation of a long-acting nanoformulated dolutegravir
    Brady Sillman
    Aditya N. Bade
    Prasanta K. Dash
    Biju Bhargavan
    Ted Kocher
    Saumi Mathews
    Hang Su
    Georgette D. Kanmogne
    Larisa Y. Poluektova
    Santhi Gorantla
    JoEllyn McMillan
    Nagsen Gautam
    Yazen Alnouti
    Benson Edagwa
    Howard E. Gendelman
    [J]. Nature Communications, 9
  • [7] Creation of a long-acting nanoformulated dolutegravir
    Sillman, Brady
    Bade, Aditya N.
    Dash, Prasanta K.
    Bhargavan, Biju
    Kocher, Ted
    Mathews, Saumi
    Su, Hang
    Kanmogne, Georgette D.
    Poluektova, Larisa Y.
    Gorantla, Santhi
    McMillan, JoEllyn
    Gautam, Nagsen
    Alnouti, Yazen
    Edagwa, Benson
    Gendelman, Howard E.
    [J]. NATURE COMMUNICATIONS, 2018, 9
  • [8] Creation of a Long-Acting Nanoformulated Dolutegravir
    Sillman, Brady
    Bade, Aditya N.
    Dash, Prasanta K.
    Bhargavan, Biju
    Kocher, Ted
    Mathews, Saumi
    Su, Hang
    Kanmogne, Georgette D.
    Poluektova, Larisa Y.
    Gorantla, Santhi
    McMillan, JoEllyn
    Gautam, Nagsen
    Alnouti, Yazen
    Edagwa, Benson
    Gendelman, Howard E.
    [J]. JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2018, 13 : S79 - S79
  • [9] Long-acting nanoformulated antiretroviral therapy elicits potent antiretroviral and neuroprotective responses in HIV-1-infected humanized mice
    Dash, Prasanta K.
    Gendelman, Howard E.
    Roy, Upal
    Balkundi, Shantanu
    Alnouti, Yazen
    Mosley, Rodney L.
    Gelbard, Harris A.
    McMillan, JoEllyn
    Gorantla, Santhi
    Poluektova, Larisa Y.
    [J]. AIDS, 2012, 26 (17) : 2135 - 2144
  • [10] Creation of a Long-Acting Nanoformulated Dolutegravir
    Sillman, Brady
    Bade, Aditya N.
    Dash, Prasanta K.
    Bhargavan, Biju
    Kocher, Ted
    Mathews, Saumi
    Su, Hang
    Kanmogne, Georgette D.
    Poluektova, Larisa Y.
    Gorantla, Santhi
    McMillan, JoEllyn
    Gautam, Nagsen
    Alnouti, Yazen
    Edagwa, Benson
    Gendelman, Howard E.
    [J]. JOURNAL OF NEUROVIROLOGY, 2018, 24 : S79 - S79